SBR00028

FITC labeled vancomycin

for fluorescent microbial imaging

Manufacturer: Sigma Aldrich

Synonym(S): Vancomycin -FITC, Vancomycin FITC conjugate

Select a Size

Pack Size SKU Availability Price
1.5 MG SBR00028-1.5-MG In Stock ₹ 25,287.20

SBR00028 - 1.5 MG

₹ 25,287.20

In Stock

Quantity

1

Base Price: ₹ 25,287.20

GST (18%): ₹ 4,551.696

Total Price: ₹ 29,838.896

Quality Level

100

Assay

≥85% (HPLC)

form

solid

mol wt

Mw 1840.66 g/mol

availability

not available in China

storage condition

protect from light

color

yellow to dark orange

suitability

suitable for (Fluorescent detection of gram-positive bacteria)suitable for (Microbiome)suitable for microbiology

antibiotic activity spectrum

Gram-positive bacteria

Mode of action

DNA synthesis

Related Products

Img

Sigma Aldrich

SBR00029

for fluorescent microbial imaging, ...

Img

Sigma Aldrich

SBR00025

100 mg/mL in water...

Img

Sigma Aldrich

S9007

potency: ≥603 μg per mg...

Img

Sigma Aldrich

T7660

powder, BioReagent, suitable for ce...

Img

Sigma Aldrich

SBR00014

1 mg/mL in DMSO...

Img

Sigma Aldrich

S9137

powder, BioReagent, suitable for ce...

Img

Sigma Aldrich

V3639

Ready Made Solution, ~1 mg/mL in DM...

Img

Sigma Aldrich

SMB00607

--

Description

  • General description: FITC labeled Vancomycin (Vancomycin-FITC), is a Fluorescein conjugated Vancomycin, with a similar mode of action as Vancomycin. Vancomycin -FITC can be used to detect Gram-positive bacteria by common fluorescent instruments. Vancomycin is a glycopeptide antibiotic, used to treat gram-positive infections. Fluorescent antibiotics are obtained by synthetic conjugation of an antibiotic to a fluorophore.
  • Application: Fluorescent antibiotics can be used for many applications including:Antimicrobial resistance research.Bacterial visualization and imaging.Parent antibiotic mode of action research and new antibiotic discovery.Toxicity studies.Research of bacterial infections and tracking its uptake in vivo.
  • Biochem/physiol Actions: Vancomycin inhibits cell wall synthesis at the level of peptidoglycan biosynthesis. Vancomycin binds with high affinity and specificity to the terminal D-Ala-D-Ala of the growing peptide chain during cell wall synthesis. The binding inhibits transpeptidase activity, which prevents further elongation and cross-linking of the peptidoglycan matrix. Vancomycin-FITC has fluorescein attached to the amine group on the disaccharide moiety of the vancomycin molecule. This disaccharide moiety does not play any role in D-Ala-D-Ala binding site, affording a comparable binding affinity of Vancomycin-FITC to Gram-positive bacteria as the parent drug. However, a minimum inhibitory concentration (MIC) decrease of about two orders of magnitude in comparison to Vancomycin was observed. This activity decrease can be linked to repulsive interactions between the negatively charged Fluorescein moiety and the anionic environment of the peptidoglycan.
  • Features and Benefits: High-quality antibiotic suitable for multiple research applicationsIdeal for immunological, biochemical, and cell biology applicationsSuitable for fluorescent microscopy imaging
  • Analysis Note: Aliquots of the DMSO solution can be stored at -20°C, protected from light for at least 1 month.Fluorescent microscopy application: Vancomycin -FITC has excitation/emission wavelength at 495 nm/515 nm. It is recommended to dissolve Vancomycin-FITC in DMSO (Dimethyl Sulfoxide) to a concentration of 1mg/mL. Recommended working concentration for Bacillus cereus in fluorescent microscopy imaging application is 25μg/mL.
  • Other Notes: For additional information on our range of Biochemicals, please complete this form.

SAFETY INFORMATION

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable